Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal mifepristone for uterine fibroids
NCT00881140Phase 2Completed
- Sponsor
- BioPro Implants
- Start
- Apr 2009
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mifepristone in uterine fibroid, sponsored by BioPro Implants. Primary endpoint: Decrease of uterine fibroids volume by 25% and up at 1 year. Started Apr 2009; status: completed.
02
Drugs
mifepristone
03
Conditions
uterine fibroid
Beyond the preview
Go deeper on NCT00881140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881140.